IHS Chemical Week

World News and Views :: Top of the News

Companies eyeing Novartis's animal health business

5:32 AM MST | December 4, 2013 | Natasha Alperowicz

Several companies have emerged as potential buyers of Novartis’s animal health business, according to press reports. Novartis’s CEO, Joe Jimenez, said last month that the company may sell its nonstrategic animal health and OTC businesses if it cannot turn them into businesses of global scale. Combined revenues of the two businesses were $3.7 billion last year, 19% down on the year before. Novartis is working with Goldman Sachs on the review of its portfolio, according to Bloomberg.   Bayer, which earlier this year acquired Teva...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa